NEW YORK (GenomeWeb) – The National Cancer Institute this month said that it has renewed a program under which it will fund the use of biosamples obtained through the Prostate, Lung, Colorectal, and Ovarian Cancer Screening (PLCO) trial in order to advance research into the etiology and early detection of cancer.

The NCI said it will support a wide range of cancer research including biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.